The Valley Desk

NCT05834738 · Interventional trial

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Overall registry status Completed

Phase 2

Conditions IgA Nephropathy, Immunoglobulin A Nephropathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov